EGFR and urinary bladder cancer: We analyzed and discussed in this article whether EGFR and HER2 are expressed with such high frequencies that targeted radionuclide therapy might be a possibility and an alternative or complement to other modalities in the treatment of metastatic urinary bladder cancers.